Bladder Cancer Clinical Trials

RSS | Login | Register

Biomarker Discovery and Application in Bladder Cancer

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Multimodal Rehabilitation Program to Bladder Cancer Patients (MRPBC)

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer

3 Tesla MRI in Patients With Bladder Cancer

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Bladder Cancer Imaging Study-OCT Imaging to Stage Bladder Tumors

Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

Genetic Susceptibility to Bladder Cancer

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer

Quality of Life in Patients With Bladder Cancer

Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer

Cone Beam Computed Tomography (CT) Bladder

Molecular Analysis Of Bladder Cancer

Quality of Life and Symptom Management in Patients With Bladder Cancer

Bladder Cancer News

Comorbid Illnesses Worsen Post-Cystectomy Outcomes

Smaller Bladder Tumors Less Like to Recur After Surgery

Extended LND Improves Outcomes in Selected Bladder Cancer Patients

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

An Update on Robotic-Assisted Partial Nephrectomy

Your Practice

Since its inception, health care providers have struggled with the need to protect patient privacy, share information, and keep paper work under control.

Read more on
Complying with HIPAA

Have any practice management topics that you'd like us to cover?
Let us know.